Skip to main content
Richard Beckman, MD, Ophthalmology, Boca Raton, FL

RichardLBeckmanMD

Ophthalmology Boca Raton, FL

Glaucoma Related

Chief Medical Officer ReNeuron, Inc.

Dr. Beckman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Beckman's full profile

Already have an account?

  • Office

    17150 Bermuda Village Dr
    Boca Raton, FL 33487

Education & Training

  • Massachusetts Eye and Ear Infirmary/Harvard Medical School
    Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Glaucoma, 1990 - 1991
  • Henry Ford Health/Henry Ford Hospital
    Henry Ford Health/Henry Ford HospitalResidency, Ophthalmology, 1987 - 1990
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 1983 - 1984
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 1983

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1994 - 2025
  • MA State Medical License
    MA State Medical License 1990 - 2007
  • MI State Medical License
    MI State Medical License 1987 - 1999
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Fellow (FAAO) American Academy of Ophthalmology

Press Mentions

  • Adverum Biotechnologies Announces New Executive Leadership Roles
    Adverum Biotechnologies Announces New Executive Leadership RolesMay 25th, 2023
  • Adverum Biotechnologies Presents Positive End of Study Results from the OPTIC Trial in Wet AMD Including Two-Year Outcomes Following a Single Intravitreal Injection of Ixo-Vec (ADVM-022)
    Adverum Biotechnologies Presents Positive End of Study Results from the OPTIC Trial in Wet AMD Including Two-Year Outcomes Following a Single Intravitreal Injection of Ixo-Vec (ADVM-022)November 5th, 2022
  • Adverum Biotechnologies Presents Anatomical Improvements in Intraretinal and Subretinal Fluid After a Single IVT Injection of Ixo-Vec (ADVM-022) in the OPTIC Study in Wet AMD
    Adverum Biotechnologies Presents Anatomical Improvements in Intraretinal and Subretinal Fluid After a Single IVT Injection of Ixo-Vec (ADVM-022) in the OPTIC Study in Wet AMDOctober 1st, 2022
  • Join now to see all

Professional Memberships